Business ❯ Corporate Governance ❯ Regulatory Compliance

Risk Management

Securities Fraud Sanofi Investor Relations Financial Reporting Investor Confidence Oversight Forward-Looking Statements

Biogen to Buy RayThera for Up to $1 Billion

The acquisition adds small-molecule anti-inflammatory candidates to Biogen’s pipeline with most payments tied to clinical and regulatory milestones.

Leak Shows $1.7 Billion in Flagged Binance Flows, Including $144 Million After U.S. Plea Deal